← Back to all signals
RESEARCH PAPER ANALYSIS

The value of targeting CXCR4 with 68Ga-Pentixafor PET/MRI for Cushing's disease: a retrospective cohort study.

AI interpretation is pending for this paper.

Open original publication →
PMID41711818
JournalEuropean journal of nuclear medicine and molecular imaging
Publication Date2026-02-19
Ingested2026-08-02 12:06 AM
EXECUTIVE SUMMARY

What the AI sees

Not AI summarized yet.

WHY IT MATTERS

Research significance

Pending deeper interpretation.

ABSTRACT

Source abstract

PURPOSE: 68Ga-pentixafor PET/MRI, which targets the C-X-C chemokine receptor type 4 (CXCR4), has been shown to significantly enhance lesion localization accuracy in Cushing’s disease (CD). However, a subgroup of CD tumors exhibits both reduced 68Ga-pentixafor uptake and low CXCR4 expression. In this study, we propose a CXCR4-based stratification of CD patients to evaluate the utility of this stratification for improving lesion localization accuracy, delineating clinical characteristics, predicting survival outcomes, and characterizing mutational features. METHODS: This retrospective study analyzed 138 patients with surgically and pathologically confirmed CD. Patient subsets underwent 68Ga-Pentixafor PET/MRI (n = 78), CXCR4 immunohistochemistry (n = 116), and targeted gene sequencing (n = 129). Follow-up data were available for 115 patients. RESULTS: The localization sensitivity and diagnostic accuracy of 68Ga-pentixafor PET/MRI reached 98.7% and 96.3% respectively, when combined with conventional contrast-enhanced MRI. The entire retrospective cohort (n = 138) was stratified into CXCR4-high (n = 95) and CXCR4-low (n = 43) groups using receiver operating characteristic (ROC) analysis. Compared with the CXCR4-high group, the CXCR4-low group exhibited a higher proportion of relapsed tumors (P = 0.005), a lower proportion of hypokalemia (P = 0.005), larger tumor diameter (P = 0.026) and volume (P = 0.013), lower ACTH staining intensity (P < 0.001), and worse progression-free survival (PFS) after 2.5 years (P = 0.041). The prevalence of tumors harboring ubiquitin-specific peptidase 8 (USP8) hotspot mutations was significantly lower in the CXCR4-low group (P = 0.04) among macroadenomas but not among microadenomas. CONCLUSION: CXCR4-targeted 68Ga-pentixafor PET/MRI helps achieve consistently high accuracy in localizing ACTH-secreting pituitary neuroendocrine tumors. CXCR4 expression demonstrates potential utility for stratifying CD patients, particularly for subtyping macroadenoma.

SUPPORTING PAPER SET

32 more papers to review

Ranked by current scoring engine
1 Nuclear export inhibition activates TP53 pathways and is a potent therapeutic strategy in atypical teratoid rhabdoid tumors. Neuro-oncology advances 56.94 2 Delayed Detection of Bilateral High-Frequency Sensorineural Hearing Loss Following Childhood Cisplatin Therapy: A Case Report. The journal of international advanced otology 59.94 3 Conservative Management of a Primary Mandibular Second Molar With Dentoalveolar Abscess in a Four-Year-Old Child With Acute Lymphoblastic Leukemia: A Case Report. Cureus 54.3 4 Machine Learning Comparison and Combined Model Optimization Based on DCE-MRI Radiomics for Preoperative Assessment of Lymphovascular Invasion in Breast Cancer: A Multicenter Study. Cancer reports (Hoboken, N.J.) 65.9 5 Pediatric ALK-Negative Anaplastic Large Cell Lymphoma With Recurrent Cutaneous Relapses: Diagnostic Challenges. Pediatric dermatology 61.62 6 A safety review of jak inhibitors for managing alopecia areata. Expert opinion on drug safety 74.06 7 Support for Disclosure of Hereditary Tumor Risk to Children and Adolescents: A Scoping Review. Japan journal of nursing science : JJNS 78.4 8 Late Ischemic Cholangiopathy After Liver Transplantation From a Deceased Donor With Situs Inversus Totalis: A Case Report. Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation 47.5 9 Lived experiences of parenting-related distress in mothers with gynecological cancer: a descriptive phenomenological study. BMC women's health 58.4 10 Vancomycin Taper-and-Pulse Therapy for Recurrent Clostridioides difficile Infection in Pediatric Acute Lymphoblastic Leukemia Patients Treated With Blinatumomab and Chemotherapy: A Report of Three Cases. Cureus 62.34 11 Percutaneous calcium phosphate cement injection for unicameral bone cysts: mid- to long-term clinical and radiographic outcomes. Frontiers in surgery 63.9 12 Radiographic evidence of thymic involution in hepatocellular carcinoma: a propensity score-matched study in viral cirrhosis. Frontiers in immunology 62.5 13 Case Report: Activated phosphoinositide 3-kinase δ syndrome mimicking Hyper-IgM syndrome: early hepatosplenomegaly as a key diagnostic clue. Frontiers in immunology 56.6 14 Herpes zoster frequency and severity in immunocompromised pediatric populations: a structured narrative review. Frontiers in pediatrics 59.0 15 Recognition and management of early complications in CAR-T cell therapy and virus-specific T-lymphocyte therapy: a practical clinical reference. Frontiers in immunology 75.5 16 Gastric dysbiosis and more severe histological gastritis in symptomatic Helicobacter pylori-infected children and adolescents without ulcers: time to rethink early eradication? Frontiers in microbiology 58.4 17 Surgical management and molecular diagnosis of pediatric cystic nephroma: a single-center case series with implications for DICER1 syndrome surveillance. Translational andrology and urology 56.9 18 Infantile Osteopetrosis with a CLCN7 Variant: An Educational Case Highlighting Integrated Diagnosis and Variant Interpretation. EJIFCC 56.0 19 Plexiform neurofibroma of the scrotum in a 16-year-old male: A case report. Urology case reports 45.5 20 Advanced Imaging Techniques for Early in-Vivo Discrimination of Fibrofolliculomas in Birt-Hogg-Dubé Syndrome. Skin research and technology : official journal of International Society for Bioengineering and the Skin (ISBS) [and] International Society for Digital Imaging of Skin (ISDIS) [and] International Society for Skin Imaging (ISSI) 57.5 21 Health Behaviors in Adolescent and Young Adult (AYA) Childhood Cancer Survivors: Prevalence, Determinants, and Comparison With Population Controls. Cancer medicine 66.9 22 Mechanism of Gu-Ben-Hua-Shi (AESS) Formula Regulating Autophagy Through Hippo-YAP Pathway in Restoring the Skin Barrier in Atopic Dermatitis. Journal of cellular and molecular medicine 76.35 23 Mapping Psychosocial Determinants for Cancer Onset: An Umbrella Review. Psycho-oncology 74.9 24 Early-onset colorectal cancer burden attributable to early-life obesity from 2000 to 2020 with projections to 2040. Cancer epidemiology 57.5 25 The effect of unique molecular identifier family size using tumor-informed circulating tumor-DNA analysis in childhood cancers. The Journal of molecular diagnostics : JMD 59.6 26 GATA3-driven CDC20 activation facilitates tumor growth and metastasis through suppressing Bax/Bcl-2 ratio and boosting EMT process in neuroblastoma. The Journal of biological chemistry 60.6 27 [Masked pediatric pathological femoral fracture : Case report of a sarcoma-associated femoral fracture after adequate trauma]. Unfallchirurgie (Heidelberg, Germany) 49.9 28 Antiviral therapies are associated with reduced mortality but under-utilized in patients with viral hepatocellular carcinoma: a multinational REAL-HCC study. Hepatology international 61.1 29 Privacy-Preserving Linkage of Distributed Biological, Clinical, and Imaging Data Supporting Artificial Intelligence in Pediatric Oncology. Methods of information in medicine 71.9 30 Risk and benefit for targeted therapy agents in paediatric phase I trials in oncology: a systematic review and meta-analysis protocol. BMJ open 83.72 31 Testicular Tissue Cryopreservation in Prepubertal Boys: Current Advances, Clinical Feasibility, and Future Directions-A Comprehensive Literature Review. Andrology 63.6 32 Opioid limiting law and opioid prescriptions among Medicaid-enrolled survivors of childhood cancer. Journal of the National Cancer Institute 57.5
PATIENT-FRIENDLY SUMMARY

The value of targeting CXCR4 with 68Ga-Pentixafor PET/MRI for Cushing's disease: a retrospective cohort study.

For education only—not personal medical advice.

Pediatric cancer research intelligence graphic
PEDIATRIC CANCER VISUAL SYSTEM

Open the Research Intelligence Map

Explore the active pediatric oncology analysis view.

Expand Intelligence View →
Full Pediatric cancer research intelligence graphic